Nancy Tresser, MD, MBA

Vice President and Chief Medical Officer Imalux, Cleveland, OH, United States 
"Nancy Tresser"

Dr. Tresser has over 15 years of experience in the medical field in various settings including academics, government and private practice. Her impressive background includes experience at the National Institutes of Health, National Institute of Neurological Disorders and Stroke, Office of the Clinical Director, in Bethesda, Maryland, where she served as Special Expert, Neuropathologist. Dr. Tresser has held the title of Assistant Professor of Pathology at the University of South Florida and University Hospitals of Cleveland/Case Western Reserve University School of Medicine. Additional past experience includes serving as Staff Neuropathologist at the James A. Haley VA Medical Center and the H. Lee Moffitt Cancer Center, both located in Tampa, Florida. Dr. Tresser has contributed to over 50 medical publications and presentations.

Mean distance: 16.34 (cluster 28)
Cross-listing: Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Smith SR, Cooperman S, Lavaute T, et al. (2004) Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Annals of the New York Academy of Sciences. 1012: 65-83
Proescholdt MA, Jacobson S, Tresser N, et al. (2002) Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. Journal of Neuropathology and Experimental Neurology. 61: 914-25
Shafiq M, Nee L, Grafman J, et al. (2001) Frontotemporal dementia: report of a familial case. Neurology. 56: S31-4
Tullio AN, Bridgman PC, Tresser NJ, et al. (2001) Neuronal Turnover in the Xenopus laevis Olfactory Epithelium During Metamorphosis Journal of Comparative Neurology. 433: 124-130
LaVaute T, Smith S, Cooperman S, et al. (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nature Genetics. 27: 209-14
McFarland HI, Lobito AA, Johnson MM, et al. (2001) Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 166: 2116-21
Steinbrecher A, Reinhold D, Quigley L, et al. (2001) Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. Journal of Immunology (Baltimore, Md. : 1950). 166: 2041-8
Steinbrecher A, Reinhold D, Quigley L, et al. (2000) Dipeptidyl peptidase IV in inflammatory CNS disease. Advances in Experimental Medicine and Biology. 477: 145-53
Caffrey M, Braddock DT, Louis JM, et al. (2000) Biophysical characterization of gp41 aggregates suggests a model for the molecular mechanism of HIV-associated neurological damage and dementia. The Journal of Biological Chemistry. 275: 19877-82
Singer BA, Tresser NJ, Frank JA, et al. (2000) Induction of experimental allergic encephalomyelitis in the NIH minipig. Journal of Neuroimmunology. 105: 7-19
See more...